Loading clinical trials...
Loading clinical trials...
Registry and Biosample Repository
The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Virtua Samson Cancer Center
Moorestown, New Jersey, United States
Virtua Health & Wellness Center
Voorhees Township, New Jersey, United States
Lancaster General Hospital
Lancaster, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
June 1, 2008
Primary Completion Date
December 1, 2030
Completion Date
December 1, 2030
Last Updated
March 4, 2026
8,000
ESTIMATED participants
Lead Sponsor
Abramson Cancer Center at Penn Medicine
NCT04712851
NCT03050268
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions